Shingles vaccine to be funded in New Zealand

November 2017
PharmacoEconomics & Outcomes News;11/18/2017, Vol. 791 Issue 1, p38
No abstract available.


Related Articles

  • Immunisation of Older People. Woodward, Michael // Journal of Pharmacy Practice & Research;Dec2012, Vol. 42 Issue 4, p316 

    The article presents recommendations by the Australian and New Zealand Society for Geriatric Medicine for vaccination of older patients, noting that aging impacts immune function and susceptibility to infection. The effectiveness and safety of various vaccines in older people are discussed, such...

  • Adult VACCINES which do you need?  // Good Health (Australia Edition);Oct2013, p60 

    The article offers information on adult vaccines for adult immunization against serious diseases. It mentions the influenza vaccine which provides protection for people on chronic health conditions such as diabetes, cardiovascular and respiratory diseases. It notes the pneumococcal vaccines...

  • Low use of herpes zoster vaccine raises concerns. Groves, Nancy; Liesegang, Thomas // Ophthalmology Times;9/1/2014, Vol. 39 Issue 16, p1 

    The article discusses the low rates of vaccination for the herpes zoster virus, also known as shingles, in the U.S. as of September 2014. Topics covered include the views of Dr. Thomas Liesegang, professor of ophthalmology at Mayo Clinic in Jacksonville, Florida, on the virus' link to...

  • Shingles vaccine safe for older adults.  // Clinical Advisor;Jun2012, Vol. 15 Issue 6, p19 

    The article discusses Vaccine Safety Datalink (VSD) project, whose result support the findings from the prelicensure clinical trials, providing reassurance that the zoster vaccine is generally safe and well-tolerated with a small increased risk of allergic reactions in 1-7 days after vaccination.

  • Prevention of Herpes Zoster in Older Adults. KOCHER, JARED // American Family Physician;11/1/2013, Vol. 88 Issue 9, p578 

    The article discusses research which investigated effectiveness and safety of vaccination against herpes zoster in older adults. It references a study conducted by A. M. Gagliardi and colleagues, published in a 2012 issue of "Cochrane Database of Systematic Reviews" journal. Among the older...

  • Evidence-Based Medicine. HERPES ZOSTER SUBUNIT VACCINE EFFICACY IN IMMUNOCOMPETENT ADULTS ≥ 50 YEARS OLD. Ehrlich, Alan // Clinical Advisor;Oct2015, Vol. 18 Issue 10, p84 

    No abstract available.

  • Prospective study reveals impact of long-term shingles. Mayor, Susan // British Journal of Hospital Medicine (17508460);Dec2013, Vol. 74 Issue 12, p671 

    The article presents the highlights of the 9th Congress of the European Union Geriatric Medicine Society that was held in Venice, Italy on October 2-4, 2013. It features the Italian multicentre study, which showed that one out of five individuals aged 50 years onwards experienced prolonged...

  • Be aware: reducing the incidence of shingles. Kochhar, Suneeta // Nursing & Residential Care;Dec2014, Vol. 16 Issue 12, p678 

    No abstract available.

  • Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Hung Fu Tseng; Yi Luo; Jiaxiao Shi; Sy, Lina S.; Tartof, Sara Y.; Sim, John J.; Hechter, Rulin C.; Jacobsen, Steven J. // Clinical Infectious Diseases;2/15/2016, Vol. 62 Issue 4, p462 

    Background. Unlike in a healthy population, the protection of herpes zoster (HZ) vaccine in end-stage renal disease (ESRD) patients might be insufficient, considering data demonstrating suboptimal response to other vaccines. The study evaluates the association between HZ vaccination and the...

  • Comment on 'Ahead of Its Time? Reflecting on New Zealand's Pharmac Following its 20th Anniversary'. Metcalfe, Scott; Grocott, Rachel; Rasiah, Dilky // PharmacoEconomics;Oct2014, Vol. 32 Issue 10, p1031 

    A letter to the editor is presented in response to the article "Ahead of Its Time? Reflecting on New Zealand's Pharmac Following its 20th Anniversary" by Robin Gauld.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics